UBS Group’s Convey Health Solutions Holdings, Inc. CNVY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,090
Closed -$7K 11574
2022
Q1
$7K Sell
1,090
-3,016
-73% -$19.9K ﹤0.01% 8923
2021
Q4
$34K Buy
4,106
+3,319
+422% +$24.4K ﹤0.01% 7289
2021
Q3
$7K Sell
787
-178
-18% -$1.58K ﹤0.01% 8378
2021
Q2
$11K Buy
+965
New +$11.2K ﹤0.01% 8005

Other funds holding CNVY

UBS Group's CNVY Position: Q2 2022 in Review

UBS Group sold out of Convey Health Solutions Holdings, Inc. (CNVY) in Q2 2022, closing a stake of 1,090 shares — an estimated $7K sold.

UBS Group first reported a position in CNVY in Q2 2021 and held it in 4 quarters. The position peaked at $34K in Q4 2021. 60 funds tracked by Wall St. Rank hold CNVY as of Q2 2022.

  • UBS Group reported no remaining Convey Health Solutions Holdings, Inc. position as of Q2 2022 after selling out during the quarter.
  • UBS Group sold 1,090 Convey Health Solutions Holdings, Inc. shares in Q2 2022, an estimated $7K.
  • UBS Group first reported a position in Convey Health Solutions Holdings, Inc. in Q2 2021 and held it in 4 quarters.
  • UBS Group's Convey Health Solutions Holdings, Inc. position peaked at $34K in Q4 2021.
  • 60 funds tracked by Wall St. Rank held Convey Health Solutions Holdings, Inc. as of Q2 2022.

Based on UBS Group's 13F filing for Q2 2022, filed 10 Aug 2022.